HC Wainwright & Co. Maintains Buy on Zymeworks, Raises Price Target to $56
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsPrice Target
HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $55 to $56.
HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $55 to $56.